‘Momentous’ UK trial to explore statin for MS
Researchers have kicked off a £6 million trial investigating the potential of simvastatin as a treatment for multiple sclerosis.
Read More
Tag: simvastatin
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
